Bivalirudin vs Heparin in ECMO Patients
NCT03707418
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
unable to secure funding
Conditions
Extracorporeal Membrane Oxygenation Complication
Interventions
DRUG:
Heparin Sodium
DRUG:
Bivalirudin Injection [Angiomax]
Sponsor
Johns Hopkins University